| Literature DB >> 12734918 |
George Wells1, Maarten Boers, Beverley Shea, Jennifer Anderson, David Felson, Kent Johnson, John Kirwan, Marissa Lassere, Vivian Robinson, Lee Simon, Vibeke Strand, Piet van Riel, Peter Tugwell.
Abstract
The MCID (minimal clinically important difference) module of OMERACT 5 developed a research agenda that led to the conclusion that a state of low disease activity for rheumatoid arthritis (RA) would need to be defined. To develop such a definition the various concepts and terminologies, the process for developing an operational definition, and the availability and design of longitudinal datasets for validation needed to be considered. This article describes the process of the MCID/Low Disease Activity State Workshop at OMERACT 6 to develop such a definition.Entities:
Mesh：
Year: 2003 PMID： 12734918
Source DB: PubMed Journal: J Rheumatol ISSN： 0315-162X Impact factor: 4.666